Exosomes can serve as delivery vehicles for advanced therapeutics. The components necessary and sufficient to support exosomal delivery have not been established. Here we connect biochemical composition and activity of exosomes to optimize exosome-mediated delivery of small interfering RNAs (siRNAs). This information is used to create effective artificial exosomes. We show that serum-deprived mesenchymal stem cells produce exosomes up to 22-fold more effective at delivering siRNAs to neurons than exosomes derived from control cells. Proteinase treatment of exosomes stops siRNA transfer, indicating that surface proteins on exosomes are involved in trafficking. Proteomic and lipidomic analyses show that exosomes derived in serum-deprived conditions are enriched in six protein pathways and one lipid class, dilysocardiolipin. Inspired by these findings, we engineer an ''artificial exosome,'' in which the incorporation of one lipid (dilysocardiolipin) and three proteins (Rab7, Desmoplakin, and AHSG) into conventional neutral liposomes produces vesicles that mimic cargo delivering activity of natural exosomes.
HIGHLIGHTS
Source cell stress augments exosome activity but reduces microvesicle activity Source cell stress alters exosome lipid and protein composition DSP, Rab7, AHSG an dilysocardiolipin enhances exosome activity INTRODUCTION Extracellular vesicles (EVs), including exosomes (small EVs) and microvesicles (large EVs), transfer molecules, such as therapeutic RNAs (Lener et al., 2015; Kramer-Albers, 2017; Kamerkar et al., 2017) , to induce phenotype change in recipient cells (Valadi et al., 2007; Zomer et al., 2015; Fruhbeis et al., 2013; Monguio-Tortajada et al., 2017; Zhang et al., 2018) . The following critical issues have impeded the use of exosomes for clinical applications: (1) production of exosomes from cells is tedious, has low yield, and is difficult to control; (2) the essential components of active exosomes are not established; and (3) the fundamental mechanisms of exosomal delivery need to be clarified to produce artificial exosomes in bulk. We optimized conditions to improve the delivery of exosomal cargo (small interfering RNA [siRNAs] ) and used these optimized exosomes to find molecules that may affect exosomal activity. We constructed artificial exosomes inspired by these findings. Our strategy aims to substitute natural exosomes with artificial exosomes appropriate for large-scale production.
Cellular stress increases the activity of EVs (Han et al., 2018; Mleczko et al., 2018; Guitart et al., 2016) , possibly by altering their protein (Xie et al., 2018; Guitart et al., 2016; Sun et al., 2014; Li et al., 2015) and RNA composition (King et al., 2012; Pope and Lasser, 2013) . Therefore relating the change in composition of EVs to the change in their activity under stressed and control conditions can establish a composition-activity relationship. Serum deprivation is a common means of inducing cellular stress (Oskowitz et al., 2011) , is widely used in extracellular vesicle production, and has been found to alter EV number (Aubertin et al., 2016; Sun et al., 2014; Taverna et al., 2003) , activity (Sun et al., 2014; Oskowitz et al., 2011; Taverna et al., 2003) , and composition (Kowal et al., 2016; Li et al., 2015) . Surface (Sun et al., 2014) and intravesicular proteins (Taverna et al., 2003) have been linked to improved EV activity upon serum deprivation. We speculated that the membrane composition (proteins and lipids) of EVs is responsible for EV intercellular trafficking activity. We showed that upon serum deprivation, producer cells release exosomes that are more efficient at delivering siRNAs to neurons (a model for intercellular trafficking). This activity change was accompanied by substantial protein and lipid composition changes. We then screened several proteins and lipids, which were enriched in stressed exosomes, for enhancement in vesicle-mediated siRNA delivery to neurons. Subsequently we combined a candidate lipid (dilysocardiolipin) and three candidate proteins (Rab7, AHSG, and Desmoplakin) from the screen into liposomes to construct ''artificial exosomes.'' These artificial exosomes mimicked the siRNA delivery activity of natural stressed exosomes both in vitro and in vivo.
RESULTS

Characterization of Extracellular Vesicles Produced from Control and Serum-Deprived Mesenchymal Stem Cells
We incubated mesenchymal stem cells derived from umbilical cord, adipose tissue, and bone marrow in either the recommended stem cell medium depleted of EVs (Control) or serum-free RPMI medium for 24 h (Stressed). We used differential ultracentrifugation to generate two EV populations, small and large EVs, enriched based on their sedimentation properties (Thery et al., 2006) . We refer to the EVs from the 10,000 3 g pellet as microvesicles and EVs from the 100,000 3 g pellet as exosomes. Throughout this study we compare stressed conditions with control conditions within the same sample type: stressed cells versus control cells, microvesicles from stressed versus from control cells, and exosomes from stressed versus from control cells.
Mesenchymal stem cells tolerated serum deprivation for up to 4 days ( Figure S1A ) without loss of viability. EVs showed homogeneous size distribution ( Figure S1B ). Exosomes and microvesicles isolated from both the control and stressed (serum deprived for 24 h) conditions displayed positive protein markers and were devoid of negative protein markers of EVs ( Figure S1C ) and appeared as lipid bilayer-surrounded vesicles on transmission electron microscopy ( Figure S1D ). Serum deprivation did not affect the exosome yield from umbilical cordderived cells (p = 0.3), but significantly decreased the exosome yield from both adipose-and bone marrowderived cells (6-fold, p = 0.04, and 10-fold, p = 0.002, respectively, Figure S2A ). Serum deprivation did not alter the amount of microvesicles ( Figure S2B ). Exosomes derived from umbilical cord mesenchymal stem cells were slightly larger than exosomes from either adipose tissue or bone marrow cells (142 G 14 nm, 110 G 19 nm, and 117 G 10 nm, respectively) . Serum deprivation did not affect EV size (Figures S2C and S2D) . Protein-to-particle ratio varied substantially between vesicles from different sources and was affected by serum deprivation for some EV populations (Figures S2E and S2F) . Umbilical cord-derived exosomes had the lowest protein-to-particle ratio, which remained unchanged upon serum deprivation (Figures S2E and S2F) .
Serum Deprivation of Mesenchymal Stem Cells Improves Exosome Activity but Impairs Microvesicle Activity
Extracellular vesicles transport RNA between cells (Valadi et al., 2007; Zomer et al., 2015; Yang et al., 2017) . We previously have shown that exosomes can productively transfer loaded cholesterol-conjugated siRNAs to neurons . We loaded Huntingtin-targeting, cholesterol-conjugated siRNA (Alterman et al., 2015) to exosomes and treated primary neurons as a model for exosome trafficking. We evaluated the rates of exosome uptake to neurons using confocal microscopy and quantified the level of guide strand accumulation and target mRNA silencing in neurons.
First, exosomes isolated from serum-deprived cells (Exosomes Stressed ) could be loaded with equal amount of siRNA as Exosomes Control ( Figure S3 ). Second, Exosomes Stressed delivered more siRNA to target neurons than Exosomes Control across all mesenchymal stem cell origins tested ( Figures 1A-1C ). Third, when loaded with fluorescently labeled siRNA, Exosomes Stressed showed an approximately 2-fold faster neuronal uptake kinetic (half-time 1.7 h versus 3.8 h, p < 0.0001) ( Figures S4A and S4B ). Finally, siRNA-containing Exosomes Stressed were 5-to 22-fold more efficient at inducing Huntingtin mRNA silencing than Exosomes Control (Figures 1D-1F ). A similar effect was observed with siRNAs targeting Ppib mRNA ( Figure S4C ).
Stress-dependent enhancement in activity was characteristic of exosomes and not of microvesicles, where serum deprivation impaired activity ( Figures 1A-1F ). These data pointed toward specific characteristics between exosomes and microvesicles that may be related to different vesicle trafficking: protein composition Kowal et al., 2016) .
Serum Deprivation of Mesenchymal Stem Cells Substantially Alters Protein Composition of Exosomes
To evaluate serum deprivation-induced changes in the protein composition of exosomes, we performed liquid chromatography-tandem mass spectrometry (LC-MS/MS) proteomic analysis. We collected data from three independent repeats of (1) control or serum-deprived mesenchymal stem cells (derived from umbilical cord, adipose tissue, or bone marrow), (2) microvesicles from control or serum-deprived cells, and (3) exosomes from control or serum-deprived cells.
As expected, serum deprivation had a profound effect on the proteome of cells, microvesicles, and exosomes, consistent in biological replicates . Protein composition differed substantially between exosomes and microvesicles ( Figures S5-S8 ). Proteins enriched in stressed exosomes were either unchanged or depleted in corresponding microvesicles and source cells (Figures S5-S8 and 2D-2F).
Gene Ontology analysis showed enrichment of extracellular exosome, proteasome, membrane, desmosome, cell-cell adhesion, ribosome, and Golgi protein pathways in Exosomes Stressed fractions throughout all cell sources tested ( Figures 2G-2I ). We hypothesized that proteins involved in membrane, desmosome, and cell-cell adhesion may be related to vesicle trafficking. In addition, categories frequently found in exosomes (multivesicular body, endosome, histone, tetraspanins) as well as categories non-canonical to exosomes (endoplasmic reticulum [ER] , ER-to-Golgi transport, and chaperone proteins) were enriched in Exosomes Stressed derived from at least two of three cell sources tested ( Figures 2G-2I ).
Several Proteins Enriched in Stressed Exosomes Contribute to Improved siRNA Transfer to Neurons
Altered protein composition may explain the enhanced activity of Exosomes Stressed . Proteinase K treatment (degrades surface proteins) impaired the exosome-mediated siRNA transfer and resulted in less Huntingtin Figure 1 . Serum Deprivation of Mesenchymal Stem Cells Improves Exosome Activity but Impairs Microvesicle Activity Primary neurons were treated with fluorescent siRNA-containing exosomes or microvesicles derived from control or stressed (serum deprived) cells. After 7 days of incubation, siRNA levels and target mRNA levels were quantified in neurons. mRNA levels were normalized to housekeeping gene and to untreated control. N = 3, mean G SEM, curves were compared using two-way ANOVA. (D-F) Heatmaps of proteins different (p < 0.1) in Exosomes Stressed versus Exosomes Control . Orange represents enrichment in stressed conditions versus control conditions (Exosomes Stressed versus Exosomes Control , Microvesicles Stressed versus Microvesicles Control , and Cells Stressed versus Cells Control ), whereas blue represents enrichment in control conditions versus stress conditions. silencing ( Figures 3A and 3B) , confirming that exosomes' surface proteins are essential for the delivery of cargo into neurons. The difference in the activity of Exosomes Stressed over Exosomes Control is not related to potential inhibition by serum proteins present, as incubation with serum-containing (EV-depleted) media had no effect on Exosomes Stressed activity ( Figure 3A ).
To establish a protein composition-activity relationship in exosomes, we selected proteins that (1) have an established role in vesicle trafficking or membrane adhesion and (2) were enriched in stressed exosomes derived from at least two of three mesenchymal stem cell sources. Based on these criteria, the shortlist included proteins from endosomal pathways (Rab5 and Rab7; Kummel and Ungermann, 2014), plasma membrane budding (ARRDC1; Nabhan et al., 2012) , secreted proteins interacting with membranes (dermcidin; Paulmann et al., 2012) , desmosome (Desmocollin, Desmoplakin; Delva et al., 2009) , and nucleoextracellular shuttles (AHSG and histone 1; Watson et al., 2012) ( Figure 3C ). AHSG has been reported to shuttle histones from the nucleus to exosomes (Watson et al., 2012) and was consistently enriched in stressed cells (not present in EVs) ( Figure 3C ), whereas histones were specifically enriched in stressed exosomes .
Purified proteins were chemically palmitoylated and co-incubated with neutral liposomes (dioleoyl-phosphatidylcholine: cholesterol, 7:3) to promote association with the liposome membrane. Palmitoylation has been reported as a strategy to enrich proteins associated with exosomal membranes (Lai et al., 2015) . Incorporation of Rab7, Desmoplakin, and AHSG improved liposome-mediated siRNA transfer to neurons and improved Huntingtin mRNA silencing (p < 0.0001 two-way ANOVA, Figure 3D ). Incorporation of Rab5, Desmocollin, ARRDC1, Dermcidin, and histone 1 had no effect ( Figure 3D ). Thus incorporation of at least three candidate proteins from the proteomic analysis to the liposome surface affected the efficiency of vesicle transfer to neurons.
Dilysocardiolipin Enrichment in Stressed Exosomes Contributes to Improved Trafficking to Neurons
Membrane composition is a likely contributor to the enhanced trafficking activity of stressed exosomes. Membrane trafficking is regulated by both proteins and lipids (Ikonen, 2001; Huijbregts et al., 2000) . To evaluate the effect of serum deprivation on the lipid composition of exosomes, we performed MS/MS ALL lipidomic analysis. Among all lipid classes detected, only cardiolipins showed significant enrichment in exosomes derived from serum-deprived cells (p = 0.004, two-way ANOVA) ( Figures 4A and S8A ). Similar to protein enrichment, cardiolipin enrichment was specific to stressed exosomes and did not occur in corresponding cells and microvesicles ( Figure 4A ). In addition, we have observed a modest but statistically significant enrichment in unsaturated and long-tailed cardiolipins in stressed exosomes (Figures S8B and S8C) .
Cardiolipin is a diphosphatidylglycerol lipid with four fatty acid tails ( Figure 4B ). Hydrolytic removal of one or two fatty acid tails results in the formation of monolysocardiolipin ( Figure 4C ) or dilysocardiolipin ( Figure 4D ), known intermediates in cardiolipin remodeling (Cao et al., 2004) . Cardiolipin remodeling has been associated with highly curved membranes (Schlame et al., 2012) .
Among different cardiolipin subclasses, dilysocardiolipins showed the highest enrichment in stressed exosomes (16-fold, p < 0.0001), followed by intact cardiolipins (9-fold, p < 0.0001) and monolysocardiolipins (6-fold, p < 0.0001) ( Figure 4E ), compared with control exosomes. Cardiolipin subclass enrichment was specific to stressed exosomes and was not observed in corresponding microvesicles and cells ( Figure 4E ).
To test whether cardiolipins play a role in vesicle trafficking to neurons, we incorporated intact cardiolipin, monolysocardiolipin, or dilysocardiolipin (30% of total lipid amount) in conventional liposomes (dioleoylphosphatidylcholine, cholesterol). Incorporation of dilysocardiolipin, but not other variants, into liposomes improved siRNA transfer to neurons and resulted in enhanced Huntingtin silencing (p = 0.007, two-way ANOVA) ( Figure 4F ). Thus dilysocardiolipin enrichment in stressed exosomes might be a contributing factor to enhanced neuronal uptake.
Artificial Exosomes Are Equally Active at siRNA Delivery as Natural Exosomes In Vitro and In Vivo
Having identified three proteins and one lipid class to be enriched in Exosomes Stressed and improve vesicle uptake into neurons, we explored whether we can engineer an artificial exosome displaying similar activity Primary neurons were then treated with the above exosome variants containing siRNAs, and mRNA levels in neurons were quantified after 7 days of incubation. N = 5, mean G SEM, curves compared using two-way ANOVA. (C) Enrichment of selected proteins in Exosomes Stressed versus Exosomes Control (orange) or in Cells Stressed versus Cells Control (gray). Proteins detected in stressed conditions but absent in control conditions were arbitrarily assigned the fold change of 20. N = 3, mean G SEM. Two-way ANOVA, ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05. (D) Primary neurons were treated with siRNA containing liposomes alone or liposomes incorporating purified proteins from (C), and target mRNA levels in neurons were quantified after 7 days of incubation. N = 4, mean G SEM, two-way ANOVA. to that of Exosomes Stressed . We combined common liposome components (dioleoylphosphatidylcholine and cholesterol) with dilysocardiolipin and palmitoylated Rab7, Desmoplakin, and AHSG in a proteoliposome (Exosome Artificial ). Incorporation of three proteins and one lipid to liposomes significantly improved liposome-mediated siRNA transfer to neurons (p < 0.0001, two-way ANOVA) ( Figure 5A ). The efficiency of siRNA-containing artificial exosomes in Huntingtin silencing was indistinguishable from that of stressed exosomes ( Figure 5A ).
To evaluate if siRNA-containing artificial exosomes will support Huntingtin silencing in vivo, we compared siRNA-containing natural exosomes and artificial exosomes infused into mouse brain. For the in vivo study, natural exosomes were produced using a combination of three-dimensional xenofree mesenchymal stem cell culture and tangential flow filtration-based exosome isolation (Exosomes Large-Scale ) . This method enabled us to collect a sufficient number of exosomes necessary to power the in vivo studies. Natural exosomes (Exosomes Large-Scale ) showed an activity indistinguishable from that of Exosomes Stressed and Exosomes Artificial in vitro in primary neurons ( Figure 5A ). When infused to the lateral ventricle of the mouse brain, both Exosomes Large-Scale and Exosome Artifical loaded with siRNAs induced Huntingtin mRNA ( Figures  5B and 5C ) silencing, whereas control liposomes, non-targeting-control siRNA containing vesicles, and non-formulated siRNA were inactive ( Figures 5B and 5C ).
DISCUSSION
EVs exhibit specific and efficient intercellular trafficking activity (Valadi et al., 2007; Zomer et al., 2015; Fruhbeis et al., 2013; Monguio-Tortajada et al., 2017; Zhang et al., 2018) and therefore are promising delivery vehicles of various classes of therapeutic proteins and RNAs (Lener et al., 2015; Kramer-Albers, 2017; Kamerkar et al., 2017) . However, the mechanisms imparting specific trafficking activity to EVs are unknown. The identification of components necessary and sufficient to make a vesicle behave like an EV would open a new chapter to overcome the delivery challenge of protein-and nucleic acid-based advanced therapeutics.
Serum deprivation of source cells may differentially influence the yield and activity of released EVs. Here we find that serum deprivation of mesenchymal stem cells increases the activity but decreases the yield of exosomes. In contrast, serum deprivation decreases the activity, but does not change the yield of Figure 5 . Artificial Exosomes Recapitulate the Activity of Stressed Exosomes (A) Primary neurons were treated with siRNA containing Exosomes Stressed , Exosome Large-Scale , or Exosomes Articial and target mRNA levels in neurons quantified after 7 days of incubation. Exosomes Stressed and Exosome Large-Scale were enriched from umbilical cord-derived mesenchymal stem cells via differential ultracentrifugation or tangential flow filtration, respectively. Exosomes Articial consisted of dioleoylphosphatidylcholine, cholesterol, dilysocardiolipin, Rab7, Desmoplakin, and AHSG. N = 5, mean G SEM, two-way ANOVA. (B and C) Huntingtin (HTT)-targeting or non-targeting control (NTC) siRNAs were infused into the lateral ventricle of mice either alone or in liposomes, Exosome Large-Scale , or Exosomes Articial . Huntingtin mRNA were quantified 4 weeks after infusion in striatum (B) and motor cortex (C). N = 5-7, mean G SD, one-way ANOVA.
microvesicles. The concept that serum deprivation may alter the yield of different EV subclasses into different directions has been raised before (Kowal et al., 2016) . However, the notion that serum deprivation may increase the activity of one EV subclass but decrease the activity of another EV subclass produced from the same cells has not been described before. This observation indicates that exosome and microvesicle production pathways are differentially regulated in stress conditions. Exosomes released from stressed cells exhibit a specific enhancement in activity and a specific protein composition. Therefore, stressed exosomes are ideally suited for composition-activity relationship studies. The protein content of EVs from serum-deprived and control cells has been shown to differ (Kowal et al., 2016; Li et al., 2015) . The functional 20S proteasome, all subunits of which we find specifically enriched in stressed exosomes, has been detected in EVs before (Bochmann et al., 2014; Kowal et al., 2016) and has been proposed to be of therapeutic value (Lai et al., 2012) . We also observe enrichment in desmosomal proteins, ribosomal proteins, histones, and endosomal proteins, all of which have been reported in EVs and are proposed to play a role in an EV release mechanism (Choi et al., 2012; Overmiller et al., 2017; Dozio and Sanchez, 2017; Keerthikumar et al., 2015; Willms et al., 2016; Nemeth et al., 2017; Watson et al., 2012) . Here we show that three of eight proteins (Desmoplakin, AHSG, and Rab7) enhance vesicle trafficking to neurons. We used chemical palmitoylation to enable protein loading into the vesicle membrane. Different proteins may have different sensitivity to this treatment (i.e., high pH and palmitoylation on lysine residues instead of the naturally occurring cysteine, serine, and threonine residues). Thus the lack of enhancement in liposome neuronal uptake may not indicate a lack of contribution to vesicle trafficking. Further advancement of the technology presented here will require combinatorial optimization of protein loading to membrane as well as lipid-to-protein ratios.
A main finding of this study is the identification of dilysocardiolipin as an essential component of exosomes. We previously have reported on cardiolipin enrichment in exosomes compared with cells and microvesicles . Lysocardiolipins are substrates of a cardiolipin-remodeling enzyme residing in the ER (acyl-coA:lysocardiolipin acyltransferase 1) (Cao et al., 2004) . The ER-Golgi secretory pathway (also enriched in stressed exosomes) may overlap with the release of exosomes from the multivesicular body (Friend, 1969; Kolesnikova et al., 2004; Nilsson et al., 2015) . Thus dilysocardiolipin may use this overlapping secretory pathway to enter exosomes under stress conditions. Artificial exosomes constructed from purified lipid and protein components would have several advantages over natural exosomes. First, the manufacture of proteoliposomes is an easily scalable process and may be more cost-effective than manufacturing cell-derived exosomes. Second, the quality control of cell-free artificial exosomes could follow established guidelines from the liposome field, whereas the quality control requirements of natural therapeutic exosomes remain unclear (Lener et al., 2015; Reiner et al., 2017) . Third, loading therapeutic cargo (proteins or RNA) into or onto artificial exosomes could be a simple step added to the manufacturing process, whereas efficient loading of therapeutic cargo to natural exosomes is still challenging.
Limitations of the Study
The activity of artificial exosome composition identified here might be limited to neuronal uptake and alteration or optimization of this composition likely is necessary to tune artificial exosomes for delivery to other cell types. The mechanism of action of dilysocardiolipin, Rab7, Desmoplakin, and AHSG may differ in natural and artificial exosomes. The method used here to load proteins onto liposomes (chemical palmitoylation) may have different efficiency for different proteins and may not be suited for all proteins. Loading proteins on the surface of neutral liposomes may alter the surface charge, which in turn may influence cellular uptake. Optimization of the loading method is needed to control the protein-to-lipid ratio in artificial exosomes.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
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Supplemental Figure 7. Proteomics analysis of bone marrow derived mesenchymal cells
and EVs under control or stressed conditions. Related to Figure 2 . Label-free quantification was carried out using the intensity-base absolute quantification method. Heatmap was then generated in R, using "pheatmap" package, hierarchical clustering of rows, scaling method:
"row". 
Transparent Methods
Oligonucleotides siRNAs were conjugated to cholesterol at the 3′end of the passenger strand via a TEG linker and were fully chemically modified with 5′-vinylphosphonate on the guide strand and an alternating pattern of 2′-O-methyls and 2′fluoros on both strands 1 . PNA oligos were purchased from PNA Bio (PNA Bio, Newbury Park, CA) . siRNA and PNA sequences and chemical modification patterns used in this study are described in Supplementary Table 1 . 
Cell culture
Umbilical cord, Wharton's jelly-derived mesenchymal stem cells (PCS -500-010, ATCC, Manassas, VA), adipose tissue derived mesenchymal stem cells (PCS-500-011, ATCC, Manassas, VA), and bone marrow derived mesenchymal stem cells (Poetics™, PT-2501, Lonza, Basel, Switzerland) were cultured in appropriate stem cell medium (PCS-500-030, ATCC, Manassas, VA, for umbilical cord and adipose tissue derived cells, and MSCGM™, PT-3238, , Lonza, Basel, Switzerland for bone marrow derived cells) in the presence of supplements containing serum and growth factors ATCC, Manassas, Lonza, Basel, Switzerland) at 37°C, 5% CO2. Medium was changed every three days, and cells expanded until passage 12, to reach a total of 3000 cm 2 surface in T500 triple flasks. For serum deprivation medium was changed to RPMI (GIBCO™ RPMI 1640, Thermo Fisher Scientific) with no FBS or other supplements added for 24 hours.
EV isolation and characterization
Medium on umbilical cord-derived mesenchymal stem cells was changed to EV-depleted medium (centrifuged at 100 000 g for at least 17 hours) or to RPMI (GIBCO™ RPMI 1640, Thermo Fisher Scientific) with no FBS or other supplements added and incubated for 24 hours.
EVs were then isolated from this conditioned medium via differential ultracentrifugation 2, 3 . Cell debris was pelleted at 300 g (10 min). Larger EVs or microvesicles were pelleted at 10 000 g (30 min), then supernatant filtered through a 0.2 µm membrane (Nalgene® aPES, Thermo Fisher Scientific, Waltham, MA) and small EVs or exosomes pelleted at 100 000 g (90 min) using 70 ml polycarbonate bottles (Beckman Coulter, Brea, CA; #355622) and Type 45 Ti rotor (Beckman Coulter, Brea, CA; #339160). Microvesicles and exosome pellets were then washed once in 1 ml sterile PBS and centrifuged again for 30 min at 10 000 g or for 90 min at 100 000 g, respectively.
For Western blot analyses, EVs or cell pellets were suspended in RIPA buffer (Pierce® 899000, Thermo Fisher Scientific, Waltham, MA) containing PMSF (36978, Thermo Fisher Scientific) and protease inhibitor cocktail (cOmplete Mini, 11836153001, Roche, Indianapolis, IN) , and samples were sonicated for 15 min. Insoluble material was pelleted by centrifugation for 15 minutes at 10 000 g, 4°C. Proteins (50µg) were loaded onto NuPAGE 4-12% Bis-Tris gels (Thermo Fisher Scientific, Waltham, MA) . After transfer to PVDF (BioRad, Hercules, CA), membranes were incubated with antibodies, washed, and images captured using an Odyssey® system (Li-Cor, Bad Homburg, Germany) according to manufacturer's instructions. Primary antibodies used were Calnexin (C5C9, Cell Signaling, Danvers, MA), Tsg101 (4A10, Abcam, Cambridge, MA), CD81 (B11, Santa Cruz Biotechnology, Dallas, TX).
Concentration and size distribution of exosomes were measured by Nanoparticle
Tracking Analysis (NanoSight NS300, Malvern). Briefly, samples were diluted in PBS 1:100 -1:1000, manually injected into the instrument and videos acquired at ambient temperature at camera level 9 for 1 minute per sample, N=3. EVs were then frozen at -80°C in 0.1M sucrose and protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, #P8340) until further use.
Transmission Electron Microscopy of EVs was conducted at Mass General Hospital using a JEOL 1100 transmission electron microscope (JEOL, Peabody, MA) at 60 kV and AMT digital camera (Advanced Microscopy Techniques, Woburn, MA). Samples and grids for were prepared at room temperature. An equal volume of 4% paraformaldehyde was added to the exosome samples and incubated for 2 hours. Aliquots of exosomes (3 μl) were dropped onto grids and incubated in 2% paraformaldehyde for 20 minutes. The grids were transferred to a wax strip and washed with 100 μl PBS. The grids were then incubated in 50 mmol/l glycine/PBS for 5 minutes and blocked in 5% bovine serum albumin/PBS for 10 minutes. The grids were then washed twice in PBS and incubated in 1% glutaraldehyde for 5 minutes. Following eight washes with water of 2 minutes each, the grids were incubated in uranyl oxalate for 5 minutes, and then in a 9:1 solution of 1% methyl cellulose and 4% uranyl acetate for 10 minutes on ice. Excess liquid was removed with a filter paper and the grids were air-dried for 5-10 minutes.
For large-scale exosome production 4 , umbilical cord-derived mesenchymal stem cells were cultured in spinner flasks (250-ml) containing on Star-Plus Microcarriers (SoloHill®, Pall Life Sciences, Port Washington, NY) in serum-free and xenofree StemPro® medium was added (A1067501, Life Technologies, Carlsbad,CA). Conditioned medium was collected after 48 hours.
Collection was performed four times; conditioned medium was stored at 4℃ and subsequently pooled together (final volume 1L). The conditioned medium was filtered through a 0.2 µm polyethersulfone (PES) membrane. Conditioned medium was then subjected to ultrafiltration (9- fold concentration) in a tangential flow filtration system using a 500 kDa cutoff TFF cartridge (MidiKros® mPES 115 cm 2 , D02-E500-05-S, Spectrum Labs, Rancho Dominguez, CA) and buffer exchanged with 6x volume of PBS. The exosomes were 0.2 µm filtered (PES membrane) and stored in 0.1M sucrose at -80℃ until further use.
siRNA loading to EVs and liposomes
EVs isolated from 3000 cm 2 mesenchymal stem cell culture were quantified (see above) and subsequently co-incubated with 150 pmol cholesterol-conjugated fluorescent (Cy3conjugated) siRNAs at 37°C for one hour in 500 µl PBS (loading mixture). Then the EV-siRNA mixture was centrifuged at 100 000 g for 90 min (for exosomes) or at 10 000 g for 30 min (for microvesicles) and supernatant containing unloaded siRNA removed (supernatant). Pellet was taken up in 50 µl PBS for quantification of loading. Fluorescence was assessed at 550 nm excitation, 570 nm emission on TECAN instrument. Percent of loaded siRNA was calculated as follows: pellet / (pellet + supernatant). To estimate siRNA copy number per EV, the following formula was used: (percent of loaded siRNA) * (amount of siRNA initially mixed in with EVs (mol)) * (Avogadro number) / (number of EVs initially mixed in).
Following quantification of loading loaded exosomes were further diluted in 250 µl Neural Q medium for treatment of primary neurons and 50 µl PBS per mouse for mouse infusions. Liposomes were loaded identical to exosomes, e.g. post-synthesis. mRNA silencing experiments were normalized to the amount of siRNA loaded in each individual EV sample.
Proteomics
Protein extraction followed the same protocol as for Western blotting. Total protein (50µg) was applied to an SDS-PAGE gel. Once the entire protein sample entered the stacking gel, electrophoresis was stopped, and the portion of gel containing proteins was excised and stained with Coomassie brilliant blue. The fixed gel fragments were processed by University of Massachusetts Medical School Mass Spectrometry Core 5 . Proteins underwent in-gel trypsin digestion for 21 hours at 37°C, extracted from gels using 80:20 solution of acetonitrile: 1% formic acid, dried in a Speed Vac and pellets redissolved in 5% acetonitrile in 0.1% trifluroacetic acid. Digested protein aliquots were injected into a custom packed 2cm x 100µm C18 Magic 5µm particle trap column and samples sprayed on a Waters Nano Acquity UPLC system. Data dependent acquisitions were performed on a Q Exactive mass spectrometer (Thermo Fisher Scientific, Waltham, MA), full MS scans from 300-1750 m/z were acquired at a resolution of 70,000 followed by 10 MS/MS scans acquired under HCD fragmentation at a resolution of 17,500 and an isolation width of 1.6 Da. Raw data files were processed with Proteome Discoverer (version 1.4) before using Mascot Server (version 2.5) to search against the Uniprot_Human protein database. Applied search parameters were fully tryptic with 2 missed cleavages, parent mass tolerances of 10 ppm and fragment mass tolerances of 0.05 Da. Search results were loaded into the Scaffold Viewer (Proteome Software, Inc.) to quantify and analyze peptides.
Lipidomics
Frozen EV pellets were transferred to BERG LLC (Framingham, MA) on dry ice for lipid composition analysis as described before 6 . Briefly, aliquots of each sample were combined with a cocktail of deuterium-labeled and odd chain fatty acid standards. Standards were chosen that represent each lipid class and were at designated concentrations expected to provide the most non-neuronal cells. Half of the volume of media was replaced with fresh NeuralQ containing anti-mitotic every 48 hours until the experiments were performed. Neurons were treated with siRNA-loaded EVs or liposomes (resuspended in NeuralQ medium) and incubated for 7 days at 37°C, 5% CO2 post treatment.
Confocal microscopy
For the analysis of siRNA-loaded exosome uptake in vitro, primary neurons were plated in poly-L-lysine (Sigma, St Louis, MO; #P4707) coated 35 mm glass bottom dishes (MatTek, Ashland, MA, #P35G-1.5-10-C) were stained with NucBlue™ live cell stain (Thermo Fisher Scientific, Waltham, MA, #R37605) and neurons were treated with exosomes conatining fluorescently labeled siRNA targeting Huntingtin gene (Suppl. Table 1 ). Images were acquired with a Leica DM IRE2 (Leica Microsystems Inc., Buffalo Grove, IL) confocal microscope using a 40x oil-immersion objective and Dapi channel (exposure time 50 ms) as well as mCherry channel (exposure time 200 ms). Images were processed using ImageJ software 9 (NIH, Bethesda, MD).
The relative uptake of siRNA, loaded in control exosomes or stressed exosomes, was estimated based on pixel integrated density of 5 images for each timepoint, and normalized to the number of nuclei per image (nuclei counted manually).
Mouse surgery
All animal procedures were approved by the University of Massachusetts Medical School Institutional Animal Care and Use Committee (IACUC, protocol number A-2411). ALZET ® osmotic pumps (ALZET Osmotic Pump, Cupertino, CA; #1003D) were prefilled with 100 µl of sample following manufacturer instructions and primed overnight at 37°C in a water bath.
Osmotic pumps were loaded with either PBS (100 µl per pump), or 6.6 x 10 10 vesicles loaded with cholesterol-siRNA (3000 copies per vesicle, total dose 0.33 nmol) (100 µl per pump), or
